Overview

A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a study of the drug tinidazole for women with recurrent bacterial vaginosis. Half of the participants will get the drug for 10 days, the other half will get the drug for 10 days and then twice a week for 12 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Kaiser Permanente
Treatments:
Tinidazole